HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Richard M O'Brien Selected Research

Glucose-6-Phosphatase (Glucose 6 Phosphatase)

11/2011Deletion of the G6pc2 gene encoding the islet-specific glucose-6-phosphatase catalytic subunit-related protein does not affect the progression or incidence of type 1 diabetes in NOD/ShiLtJ mice.
11/2008Foxa2 and MafA regulate islet-specific glucose-6-phosphatase catalytic subunit-related protein gene expression.
1/2008Long-range enhancers are required to maintain expression of the autoantigen islet-specific glucose-6-phosphatase catalytic subunit-related protein in adult mouse islets in vivo.
12/2006Deletion of the gene encoding the ubiquitously expressed glucose-6-phosphatase catalytic subunit-related protein (UGRP)/glucose-6-phosphatase catalytic subunit-beta results in lowered plasma cholesterol and elevated glucagon.
12/2005The glucose-6-phosphatase catalytic subunit gene promoter contains both positive and negative glucocorticoid response elements.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Richard M O'Brien Research Topics

Disease

6Type 2 Diabetes Mellitus (MODY)
01/2022 - 07/2009
5Type 1 Diabetes Mellitus (Autoimmune Diabetes)
11/2011 - 07/2004
3Glycogen Storage Disease (Glycogenosis)
01/2022 - 12/2006
2Hypoglycemia (Reactive Hypoglycemia)
11/2020 - 12/2006
2Hepatocellular Carcinoma (Hepatoma)
01/2009 - 12/2005
1Metabolic Diseases (Metabolic Disease)
01/2022
1Obesity
01/2020
1Glucose Intolerance
01/2020
1Hemolytic Anemia
01/2020
1Body Weight (Weight, Body)
01/2017
1Hyperinsulinism (Hyperinsulinemia)
01/2017
1Insulin Resistance
05/2013
1Hypercholesterolemia
12/2006
1Hypertriglyceridemia
12/2006
1Neoplasms (Cancer)
07/2004
1Insulinoma
07/2004

Drug/Important Bio-Agent (IBA)

5Blood Glucose (Blood Sugar)IBA
01/2022 - 05/2013
5Glucose-6-Phosphatase (Glucose 6 Phosphatase)IBA
11/2011 - 12/2005
3Proteins (Proteins, Gene)FDA Link
11/2011 - 01/2008
3AutoantigensIBA
11/2008 - 07/2004
2Insulin (Novolin)FDA Link
01/2020 - 01/2017
2Glucose (Dextrose)FDA LinkGeneric
01/2020 - 05/2013
2Amino AcidsFDA Link
01/2016 - 07/2009
1EnzymesIBA
01/2022
1Phosphoric Monoester Hydrolases (Phosphatases)IBA
01/2022
1Nonesterified Fatty Acids (NEFA)IBA
01/2017
1CholesterolIBA
01/2017
1Glucagon (Glukagon)FDA Link
01/2017
1zinc-binding protein (zinc binding protein)IBA
12/2016
1ZincIBA
12/2011
1AutoantibodiesIBA
07/2009
1EpitopesIBA
07/2009
1Epidermal Growth Factor (EGF)IBA
01/2009
1Transcription Factors (Transcription Factor)IBA
11/2008
1Liver GlycogenIBA
12/2006
1GlucocorticoidsIBA
12/2005
1Chloramphenicol O-Acetyltransferase (Chloramphenicol Acetyltransferase)IBA
07/2004

Therapy/Procedure

1Ketogenic Diet
11/2020